Next Article in Journal
The Principles, Mechanisms, and Benefits of Unconventional Agents in the Treatment of Biofilm Infection
Previous Article in Journal
Disruption of Cholinergic Circuits as an Area for Targeted Drug Treatment of Alzheimer’s Disease: In Vivo Assessment of Short-Term Plasticity in Rat Brain
Open AccessCommunication

Impact of S1P Mimetics on Mesenteric Ischemia/Reperfusion Injury

1
Department of Medicine and Surgery, University of Parma, via Gramsci 14, 43126 Parma, Italy
2
Food and Drug Department, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy
3
Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2020, 13(10), 298; https://doi.org/10.3390/ph13100298
Received: 31 July 2020 / Revised: 24 September 2020 / Accepted: 7 October 2020 / Published: 9 October 2020
(This article belongs to the Section Pharmacology)
Mesenteric ischemia/reperfusion (I/R), following the transient deprivation of blood flow to the gut, triggers an acute flogistic process involving the disruption of endothelial and epithelial barriers integrity, the activation of immune cells, and the abundant release of inflammatory mediators. Among them, the lipid mediator sphingosine-1-phosphate (S1P) is involved in maintaining epithelial and endothelial barrier integrity and in governing the migration of immune cells through the interaction with S1P1–5 receptors. Therefore, the present work aims to investigate the involvement of S1P signaling in intestinal I/R-induced injury by studying the effects of FTY720, the non-selective S1P1,3–5 agonist, and comparing them with the responses to ozanimod, selective S1P1,5 agonist, in a murine model of gut I/R. Intestinal edema, gut and lung neutrophil infiltration, and oxidative stress were evaluated through biochemical and morphological assays. The collected results highlight the protective action of FTY720 against the inflammatory cascade elicited by mesenteric I/R injury, mainly through the control of vascular barrier integrity. While these beneficial effects were mimicked by ozanimod and can be therefore attributed largely to the effects exerted by FTY720 on S1P1, the recruitment of myeloid cells to the injured areas, limited by FTY720 but not by ozanimod, rather suggests the involvement of other receptor subtypes. View Full-Text
Keywords: sphingosine-1-phosphate; gut hypoxia-reperfusion; FTY720; ozanimod; inflammation; S1P1 sphingosine-1-phosphate; gut hypoxia-reperfusion; FTY720; ozanimod; inflammation; S1P1
Show Figures

Figure 1

MDPI and ACS Style

Potì, F.; Giorgio, C.; Zini, I.; Nofer, J.-R.; Vivo, V.; Palese, S.; Ballabeni, V.; Barocelli, E.; Bertoni, S. Impact of S1P Mimetics on Mesenteric Ischemia/Reperfusion Injury. Pharmaceuticals 2020, 13, 298.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop